R & D

Halewood Labs has a long term commitment to developing Generics with the help of world class research and high quality standards. Our research and development team consists of scientists and developers who are highly qualified and experienced in formulation and analytical development. Our focus remains on continuing to develop new formulations in various dosage forms including Solid dosage, liquid dosage, Sterile preparations, injectables, Creams, ointments etc.,.

The highlights of the R&D centres at Halewood Labs include:

Development of Generics
Strict Compliance IPR / Non-infringing route
Infrastructure includes facility for scale-up & validation
Capability includes handling complex chemistries
Regulatory complaint development & scale-up

The dosage forms and technologies developed by our R&D include:

Immediate Release Solid Dosage Form (IR)
Sustained Release tablet Technology (DR)
Effervescent Technology
Enteric Coated Technology
Oro dispersible tablet form
Chewable tablet form
Tablet in capsule technology

Once a pharmaceutical product is developed, it undergoes the following:

Conceiving and identifying product profile
Pre formulation studies
Lab formula development and development for stability & validation
Scale up for process optimization /validation
Analytical method development
Pilot scale mfg in cGMP facility (Clinical supplies)
Stability studies as per ICH guidelines
Dossier preparation for submission/Technical assistance for contract manufacturing
Data management (for transfer to customer/ regulatory Affairs)